Brandywine Managers, LLC Fulcrum Therapeutics, Inc. Transaction History

Brandywine Managers, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	BUY	$9.96 - $23.65 $8,436 - $20,031	847 Added 3.35%	26,127 $618,000
Q4 2021 Feb 10, 2022	BUY	$14.0 - $28.44 $68,488 - $139,128	4,892 Added 23.99%	25,280 $447,000
Q3 2020 Nov 16, 2020	BUY	$7.22 - $20.7 $36,100 - $103,500	5,000 Added 32.49%	20,388 $162,000
Q1 2020 May 15, 2020	BUY	$9.49 - $21.26 $37,960 - $85,040	4,000 Added 35.12%	15,388 $184,000
Q4 2019 Feb 13, 2020	SELL	$4.46 - $18.14 $81,671 - $332,179	-18,312 Reduced 61.66%	11,388 $189,000
Q3 2019 Nov 13, 2019	BUY	$6.64 - $14.89 $197,208 - $442,233	29,700 New	29,700 $197,000

150

52.2M

6.91M

1.9M

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $157M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of Brandywine Managers, LLC, based on Form 13F filings with the SEC.

Stay updated on Brandywine Managers, LLC with notifications on news.